Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis: results of a 2-year prospective randomised multicentre study (INCOMIN)
Luca Durelli(University of Turin), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), E. Verdun(University of Turin), Mauro Bergui(University of Turin), Angelo Ghezzi, Enrico Montanari(University of Ferrara), Elisabetta Versino(University of Turin), Pierangelo Barbero(Ospedale San Luigi Gonzaga)
Cited by 552
Related Papers
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study
|The Lancet|2001|1.1k
Evidence of early cortical atrophy in MS
|Neurology|2003|485
Multiple sclerosis in childhood: clinical features of 149 cases
|Multiple Sclerosis Journal|1997|309
Clinical characteristics, course and prognosis of relapsing Devic?s Neuromyelitis Optica
|Journal of Neurology|2004|268
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes
|The Lancet Neurology|2005|252